Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.64 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.61 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.58 |
| ▸ | GSK3A | P49840 | 1/20 | 0.58 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.58 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.58 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.57 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.57 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.57 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14394700 | 1.00 | P2RY12 (0.64) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL23169438 | 0.92 | LMNA (0.57) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL13170100 | 0.92 | LMNA (0.71) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL6597269 | 0.92 | P2RY12 (0.63) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL6597278 | 0.92 | P2RY12 (0.63) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL17824398 | 0.89 | P2RY12 (0.81) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL30666149 | 0.89 | P2RY12 (0.81) | P2RY12DNPH1P2RY2P2RY1P2RY6 | |
| SCHEMBL233209 | 0.88 | LMNA (0.72) | LMNAALDH1A1GLAPMP22SMN1; SMN2 | |
| SCHEMBL19485512 | 0.88 | LMNA (0.72) | LMNAALDH1A1GLAPMP22SMN1; SMN2 | |
| SCHEMBL21953578 | 0.88 | LMNA (0.72) | LMNAALDH1A1GLAPMP22SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1878470-B1 | Skin depigmentation method | OREAL (FR) | 2009-03-11 | — | — | EP | disclosed |
| EP-1878470-A1 | Skin depigmentation method | L'Oréal (FR) | 2008-01-16 | — | — | EP | disclosed |
| US-20070258921-A1 | PROCESS FOR DEPIGMENTING THE SKIN | L'OREAL (FR) | 2007-11-08 | — | — | US | disclosed |
| US-20070237734-A1 | ANTI-WRINKLE COSMETIC COMPOSITION | L'OREAL (FR) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258921-A1 | PROCESS FOR DEPIGMENTING THE SKIN | TYR, CUTA, NQO1 | P2RY12 4111/4885DNPH1 435/4885P2RY2 4552/4885 |
| US-20070237734-A1 | ANTI-WRINKLE COSMETIC COMPOSITION | ADORA2A, ADORA3, ADORA1 | P2RY12 329/4885DNPH1 1518/4885P2RY2 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.